Page 11 - South Korean (KOSPI) Growth Pharmaceuticals & Biotech Stocks

UPDATED Apr 19, 2024

Discover South Korean Pharmaceuticals & Biotech Growth Stocks that are on the KOSPI. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

250 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

A372320

Curocell
₩32,000.00-2.0%n/a₩435.6bn/an/an/an/a

A461030

IMB Dx
₩19,950.00-3.6%n/a₩279.2bn/an/an/an/a

A314130

Genome
₩7,050.00-9.5%-68.5%₩105.6bn/aPS7.4xn/an/a

A338840

Y-Biologics
₩9,600.00-2.8%n/a₩141.7bn/an/an/an/a

A009290

Kwang Dong Pharmaceutical
₩6,580.00-5.5%14.0%₩268.1bn/aPE7.1xn/a1.5%

A047920

HLB Pharmaceutical
₩31,450.00-0.5%120.9%₩441.6bn/an/an/an/a

A168330

Naturalendo Tech
₩2,515.00-3.1%-15.7%₩79.4bn/aPS4.2xn/an/a

A102940

Kolon Life Science
₩22,200.00-0.2%-33.9%₩253.4bn/aPS2xn/an/a

A950200

Psomagen
₩4,725.00-3.3%-37.4%₩90.9bn/aPS2.8xn/an/a

A445680

Curiox Biosystems
₩48,700.002.4%n/a₩390.7bn/aPS57.6xn/an/a
Page 11 of 11
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.